AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 285: E481-E489, 2003; doi:10.1152/ajpendo.00060.2003
0193-1849/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Binas, B.
Right arrow Articles by Bonen, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Binas, B.
Right arrow Articles by Bonen, A.

A null mutation in H-FABP only partially inhibits skeletal muscle fatty acid metabolism

Bert Binas,1 Xiao-Xia Han,5 Erdal Erol,1 Joost J. F. P. Luiken,2 Jan F. C. Glatz,2 David J. Dyck,5 Rafat Motazavi,4 Peter J. Adihetty,4 David A. Hood,3,4 and Arend Bonen5

1Department of Pathobiology, College of Veterinary Medicine, Texas A & M University, College Station, Texas 77843; 2Department of Physiology, Maastricht University, 6200 MD Maastricht, The Netherlands; Departments of 3Biology and 4Kinesiology and Health Sciences, York University, Toronto, Ontario M3J 1P3; and 5Department of Human Biology and Nutritional Sciences, University of Guelph, Guelph, Ontario, N1G 2W1 Canada

Submitted 9 February 2003 ; accepted in final form 25 April 2003

The low-molecular-mass, cytosolic heart-type fatty acid-binding protein (H-FABP) is thought to be required for shuttling FA through the cytosol. Therefore, we examined the effects of an H-FABP-null mutation on FA and carbohydrate metabolism in isolated soleus muscle at rest and during a period of increased metabolic demand (30-min contraction). There were lower concentrations of creatine phosphate (-41%), ATP (-22%), glycogen (-34%), and lactate (-31%) (P < 0.05) in H-FABP-null soleus muscles, but no differences in citrate synthase and {beta}-3-hydroxyacyl-CoA dehydrogenase activities or in the intramuscular triacylglycerol (TAG) depots. There was a 43% increase in subsarcolemmal mitochondria in H-FABP-null solei. FA transport was reduced by 30% despite normal content of sarcolemmal long-chain fatty acid transporters fatty acid translocase/CD36 and plasma membrane-associated FABP transport proteins. Compared with wild-type soleus muscles, the H-FABP-null muscles at rest hydrolyzed less TAG (-22%), esterified less TAG (-49%), and oxidized less palmitate (-71%). The H-FABP-null soleus muscles retained a substantial capacity to increase FA metabolism during contraction (TAG esterification by +72%, CO2 production by +120%), although these rates remained lower (TAG esterification -26% and CO2 production -64%) than in contracting wild-type soleus muscles. Glycogen utilization during 30 min of contraction did not differ, whereas glucose oxidation was lower at rest (-24%) and during contraction (-32%) in H-FABP-null solei. Although these studies demonstrate that the absence of H-FABP alters rates of FA metabolism, it is also apparent that glucose oxidation is downregulated. The substantial increase in FA metabolism in contracting H-FABP-null muscle may indicate that other FABPs are also present, a possibility that we were not able to completely eliminate.

palmitate; esterification; oxidation; soleus; glucose



Address for reprint requests and other correspondence: A. Bonen, Dept. of Human Biology and Nutritional Sciences, Univ. of Guelph, Guelph, Ontario, N1G 2W1 Canada (E-mail: abonen{at}uoguelph.ca).




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Ranalletta, X. Q. Du, Y. Seki, A. S. Glenn, M. Kruse, A. Fiallo, I. Estrada, T.-S. Tsao, A. E. Stenbit, E. B. Katz, et al.
Hepatic response to restoration of GLUT4 in skeletal muscle of GLUT4 null mice
Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1178 - E1187.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
X.-X. Han, A. Chabowski, N. N. Tandon, J. Calles-Escandon, J. F. C. Glatz, J. J. F. P. Luiken, and A. Bonen
Metabolic challenges reveal impaired fatty acid metabolism and translocation of FAT/CD36 but not FABPpm in obese Zucker rat muscle
Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E566 - E575.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
B. Li, H. N. Zerby, and K. Lee
Heart fatty acid binding protein is upregulated during porcine adipocyte development
J Anim Sci, July 1, 2007; 85(7): 1651 - 1659.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Bonen, X.-X. Han, D. D. J. Habets, M. Febbraio, J. F. C. Glatz, and J. J. F. P. Luiken
A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1740 - E1749.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. C. Heather, M. A. Cole, C. A. Lygate, R. D. Evans, D. J. Stuckey, A. J. Murray, S. Neubauer, and K. Clarke
Fatty acid transporter levels and palmitate oxidation rate correlate with ejection fraction in the infarcted rat heart
Cardiovasc Res, December 1, 2006; 72(3): 430 - 437.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. R. Benton, X.-X. Han, M. Febbraio, T. E. Graham, and A. Bonen
Inverse relationship between PGC-1{alpha} protein expression and triacylglycerol accumulation in rodent skeletal muscle
J Appl Physiol, February 1, 2006; 100(2): 377 - 383.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Shearer, P. T. Fueger, D. P. Bracy, D. H. Wasserman, and J. N. Rottman
Partial Gene Deletion of Heart-Type Fatty Acid-Binding Protein Limits the Severity of Dietary-Induced Insulin Resistance
Diabetes, November 1, 2005; 54(11): 3133 - 3139.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Shearer, P. T. Fueger, J. N. Rottman, D. P. Bracy, B. Binas, and D. H. Wasserman
Heart-type fatty acid-binding protein reciprocally regulates glucose and fatty acid utilization during exercise
Am J Physiol Endocrinol Metab, February 1, 2005; 288(2): E292 - E297.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. Erol, G. W. Cline, J. K. Kim, H. Taegtmeyer, and B. Binas
Nonacute effects of H-FABP deficiency on skeletal muscle glucose uptake in vitro
Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E977 - E982.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.